CEO: | Bharatt Chowrira |
Independent Non-Executive Director: | Sharon Barber-Lui |
Independent Non-Executive Director: | John LaMattina |
Independent Non-Executive Director: | Kiran Mazumdar Shaw |
Interim Chairman: | Raju Kucherlapati |
Non-Executive Dir: | H. Robert Horvitz, Robert Langer |
Address: | 8th Floor, 20 Farringdon Street, London, United Kingdom, EC4A 4AB |
Website: | http://www.puretechhealth.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE 250, FTSE 350, FTSE All-Share |
Overseas Listings: | BATSLON:PRTCL |
ISIN: | GB00BY2Z0H74 |
Currency | UK Pounds |
Share Price | 222.00p |
Change Today | -1.00p |
% Change | -0.45 % |
52 Week High | 241.50 |
52 Week Low | 140.40 |
Volume | 184,335 |
Shares Issued | 270.41m |
Market Cap | £600.32m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
16:35 | 84,219 @ 222.00p |
16:35 | 1,460 @ 222.00p |
16:35 | 1,011 @ 222.00p |
16:35 | 747 @ 222.00p |
16:35 | 264 @ 222.00p |
You are here: research